Masimo Corporation (MASI)

Market Cap	9.16B
Revenue (ttm)	2.09B
Net Income (ttm)	-304.90M
Shares Out	53.95M
EPS (ttm)	-5.72
PE Ratio	n/a
Forward PE	32.37
Dividend	n/a
Ex-Dividend Date	n/a

Volume	470,896
Open	169.84
Previous Close	167.61
Day's Range	167.76 - 170.80
52-Week Range	101.61 - 194.88
Beta	1.03
Analysts	Buy
Price Target	194.80 (+14.71%)
Earnings Date	May 6, 2025

About MASI

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, methemoglobin, hemoglobin, fractional arter...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 8, 2007
• Employees: 3,600
• Stock Exchange: NASDAQ
• Ticker Symbol: MASI
• Website: https://www.masimo.com

Analyst Forecast

According to 6 analysts, the average rating for MASI stock is "Buy." The 12-month stock price forecast is $194.8, which is an increase of 14.71% from the latest price.

Price Target

$194.8

(14.71% upside)

Analyst Consensus: Buy